These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1832081)

  • 61. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N; Sausville EA; Breitman TR
    Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retinoids, breast cancer and NK cells.
    Villa ML; Ferrario E; Trabattoni D; Formelli F; De Palo G; Magni A; Veronesi U; Clerici E
    Br J Cancer; 1993 Nov; 68(5):845-50. PubMed ID: 8217599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
    Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M
    Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration.
    Thaller C; Shalev M; Frolov A; Eichele G; Thompson TC; Williams RH; Dillioglugil O; Kadmon D
    J Clin Oncol; 2000 Nov; 18(22):3804-8. PubMed ID: 11078493
    [TBL] [Abstract][Full Text] [Related]  

  • 66. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
    Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
    Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat.
    Neubauer BL; Bemis KG; Best KL; Goode RL; Merriman RL; Smith GF; Tanzer LR; Hoover DM
    Prostate; 1986; 8(3):265-76. PubMed ID: 3703746
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system.
    Pollard M; Luckert PH
    Prostate; 1987; 11(3):219-27. PubMed ID: 3684782
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-(4-hydroxyphenyl)retinamide (4-HPR) decreases neoplastic properties of human prostate cells: an agent for prevention.
    Sharp RM; Bello-DeOcampo D; Quader ST; Webber MM
    Mutat Res; 2001 Sep; 496(1-2):163-70. PubMed ID: 11551492
    [TBL] [Abstract][Full Text] [Related]  

  • 70. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
    Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of biomarker modulation by fenretinide in prostate cancer patients.
    Urban D; Myers R; Manne U; Weiss H; Mohler J; Perkins D; Markiewicz M; Lieberman R; Kelloff G; Marshall M; Grizzle W
    Eur Urol; 1999; 35(5-6):429-38. PubMed ID: 10325501
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
    Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
    Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading.
    Slayter MV; Anzano MA; Kadomatsu K; Smith JM; Sporn MB
    Cancer Res; 1994 Mar; 54(6):1440-5. PubMed ID: 8137245
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats.
    Christov KT; Moon RC; Lantvit DD; Boone CW; Steele VE; Lubet RA; Kelloff GJ; Pezzuto JM
    Cancer Res; 2002 Sep; 62(18):5178-82. PubMed ID: 12234981
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells.
    Mehta RR; Hawthorne ME; Graves JM; Mehta RG
    Eur J Cancer; 1998 May; 34(6):902-7. PubMed ID: 9797705
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.
    Simile MM; Pagnan G; Pastorino F; Brignole C; De Miglio MR; Muroni MR; Asara G; Frau M; Seddaiu MA; Calvisi DF; Feo F; Ponzoni M; Pascale RM
    Carcinogenesis; 2005 Feb; 26(2):417-27. PubMed ID: 15498786
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells.
    Bunk MJ; Kinahan JJ; Sarkar NH
    Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligonucleotide is enhanced by N-(2-hydroxyphenyl)all-trans retinamide.
    Campbell MJ; Dawson M; Koeffler HP
    Br J Cancer; 1998 Mar; 77(5):739-44. PubMed ID: 9514052
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of hormones on N-(4-hydroxyphenyl) retinamide inhibition of 7,12-dimethylbenz[alpha]anthracene transformation of mammary cells in organ culture.
    Chatterjee M; Banerjee MR
    Cancer Lett; 1982 Sep; 16(3):239-45. PubMed ID: 6217889
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Teratogenicity of N-(4-hydroxyphenyl)-all-trans-retinamide in rats and rabbits.
    Kenel MF; Krayer JH; Merz EA; Pritchard JF
    Teratog Carcinog Mutagen; 1988; 8(1):1-11. PubMed ID: 2897720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.